Pharma Reviews: China is a 'big opportunity' for Sun Pharma, says founder Dilip Shanghvi

With a recovery underway in its US business, Sun Pharma's billionaire ... The $160 billion Chinese drug market “is now a focus for Indian generics" as ...
Read more: China is a 'big opportunity' for Sun Pharma, says founder Dilip Shanghvi